MORGAN UEBELE: Open Payments
NPI 1447709084 · LEOLA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,215 in 187 payments from 23 companies in 2025. Trend: 2023 $1,749 · 2024 $2,441 · 2025 $3,215
Food & beverage: $3,215
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $553 |
| Janssen Biotech, Inc. | 19 | $385 |
| Organon LLC | 20 | $300 |
| GENZYME CORPORATION | 10 | $284 |
| Novartis Pharmaceuticals Corporation | 17 | $260 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $187 |
| Regeneron Healthcare Solutions, Inc. | 7 | $182 |
| Galderma Laboratories, L.P. | 10 | $174 |
| Incyte Corporation | 8 | $158 |
| Botanix SB Inc | 12 | $146 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, RINVOQ, OPZELURA, SOFDRA, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
